Navigation Links
CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System
Date:10/24/2008

applications of the MedClose(TM) system to meet other vascular closure needs and, thereby, our opportunities for broader commercialization success."

"We are pleased to help bring innovative solutions like MedClose(TM) to patients and the medical community," said Ben Clawson, co-founder and CEO of BC Tech. "We are eager to begin collaborating with CPC of America as it embarks on its manufacturing and commercialization plans."

About CPC

CPC of America acquires, develops and oversees the manufacturing of therapeutic devices for use in endovascular procedures. CPC's current focus is the completion of development and testing of the MedClose(TM) vascular closure system, an internal puncture-closing system for use in catheter laboratories.

About BC Tech

BC Tech is a full-service medical and biotech company that offers complete research, development, manufacturing and support services for Class I, II, and III medical devices, disposables, and lab automation equipment. Over the last 15 years, BC Tech has completed more than a hundred projects for satisfied customers around the world.

Forward Looking Statements

The statements contained in this press release that are not historical are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding the Company's expectations, beliefs, intentions or strategies regarding the future. Such forward-looking statements relate to, among other things: (1) the Company's continuing development of its MedClose(TM) vascular closure system, (2) the Company's expectations concerning regulatory approvals of the MedClose system and the commencement of revenue producing operations based on the sale or licensing of the MedClose, (3) the business relationship between the Company and BC Tech and t
'/>"/>

SOURCE CPC of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Cartesian Gridspeed Opens Subsidiary Operation in North America
3. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
4. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
5. American Oriental Bioengineering Announces Participation in September Investor Conferences
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
9. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
10. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
11. DaVita to Present at UBS Best of Americas Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Nearly everyone ... serious diseases. Yet few people realize that a rich source of these cells is ... adults, and teeth that need to be pulled to make room for braces. ...
(Date:7/28/2015)... , July 28, 2015  PDL BioPharma, Inc. (PDL, ... that the Company will release its second quarter 2015 ... on Wednesday, August 5, 2015, after market close. PDL,s ... day at 4:30 p.m. Eastern Time to discuss the ... will be available via the webcast link on the ...
(Date:7/28/2015)... 21, 2015 Research ... addition of the "Analysis of the Global ... offering. Globally, flow cytometry remains a ... proliferation, cancer, and stem cells. But the market ... because of demand from underdeveloped nations to quantitate ...
(Date:7/28/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) or ("Tauriga" ... announced that its stockholders approved an increase in the ... Company from 1,000,000,000 to 2,500,000,000 at its Special Meeting ... Law Offices of Nixon Peabody LLP in Midtown Manhattan ... 480,655,929 shares of common stock represented either by proxy ...
Breaking Biology Technology:Advanced Oral and Maxillofacial Surgery (AOMS) in Elmhurst, IL Partners with Provia Labs to make Store-A-Toothâ„¢ Dental Stem Cell Banking Available to their Patients 2PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Analysis of the Global Flow Cytometry Market 2012-2018 with a 2014 Base Year and a 2015-2018 Forecast Period 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3
... June 3 Reportlinker.com announces that a new market research report is available in its catalogue: ... Biomarkers - technologies, markets and companies , ... , , , ... This report follows the broad definition of a ...
... ... Researchers to Stay Informed on Current ePRO Topics , ... Pittsburgh, PA (Vocus) June 3, 2010 -- ... for global clinical research, today announced two additions to its ongoing, PROficiency™ educational program. ...
... , , ... , , ... , , , ... announces positive Phase III data from its,second pivotal study (PEARL I) for its lead product Esmya (ulipristal,acetate), ...
Cached Biology Technology:Reportlinker Adds Biomarkers - Technologies, Markets and Companies 2Reportlinker Adds Biomarkers - Technologies, Markets and Companies 3Reportlinker Adds Biomarkers - Technologies, Markets and Companies 4Reportlinker Adds Biomarkers - Technologies, Markets and Companies 5Reportlinker Adds Biomarkers - Technologies, Markets and Companies 6Reportlinker Adds Biomarkers - Technologies, Markets and Companies 7Reportlinker Adds Biomarkers - Technologies, Markets and Companies 8Reportlinker Adds Biomarkers - Technologies, Markets and Companies 9Reportlinker Adds Biomarkers - Technologies, Markets and Companies 10Reportlinker Adds Biomarkers - Technologies, Markets and Companies 11Reportlinker Adds Biomarkers - Technologies, Markets and Companies 12Reportlinker Adds Biomarkers - Technologies, Markets and Companies 13Reportlinker Adds Biomarkers - Technologies, Markets and Companies 14Reportlinker Adds Biomarkers - Technologies, Markets and Companies 15Reportlinker Adds Biomarkers - Technologies, Markets and Companies 16Reportlinker Adds Biomarkers - Technologies, Markets and Companies 17Reportlinker Adds Biomarkers - Technologies, Markets and Companies 18Reportlinker Adds Biomarkers - Technologies, Markets and Companies 19Reportlinker Adds Biomarkers - Technologies, Markets and Companies 20Reportlinker Adds Biomarkers - Technologies, Markets and Companies 21Reportlinker Adds Biomarkers - Technologies, Markets and Companies 22Reportlinker Adds Biomarkers - Technologies, Markets and Companies 23Reportlinker Adds Biomarkers - Technologies, Markets and Companies 24Reportlinker Adds Biomarkers - Technologies, Markets and Companies 25invivodata Expands Spring Educational Program 2invivodata Expands Spring Educational Program 3PregLem Announces Positive Phase III Results for Esmya(TM) 2PregLem Announces Positive Phase III Results for Esmya(TM) 3PregLem Announces Positive Phase III Results for Esmya(TM) 4
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
(Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... 2009, New York, N.Y./Los Angeles, Calif.: Stand Up ... $9.68 million to support high-risk/high-reward cancer research conducted by ... will receive a total of up to $750,000 as ... the next generation of cancer research leaders. "We ...
... of more of humanity,s food if steps are taken to ... in the December 2009 issue of BioScience. ... water and space mean that terrestrial agriculture is unlikely to ... Duarte of the University of the Balearic Islands, Spain, and ...
... with one another for space and dominance. Though the manner in ... the survival of the fittest, how stem cells duke it out ... fruit flies published in the October 2 issue of Science ... battle by literally sticking around. "Our work exemplifies how one ...
Cached Biology News:Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Stem cells battle for space 2
Neutrophil cytosol factor 2 (NCF-2) (Neutrophil NADPH oxidase factor 2) (67 kDa neutrophil oxidase factor) (p67-phox) (NOXA2). [Source:Uniprot/SWISSPROT;Acc:P19878] Antigen: Recombinant Protein E...
Rad51, N-terminal...
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Anti-T7 [Agarose Immobilized] Goat Immunogen: ... site (MASMTGGQQMG). Antibody was isolated ... on solid support. Goat anti- human T7 ... beads using cyanogens bromide method. ...
Biology Products: